MX2016014962A - Asociacion de un tetrapeptido y un ester de glicerilo para el tratamiento contra alopecia androgenica. - Google Patents

Asociacion de un tetrapeptido y un ester de glicerilo para el tratamiento contra alopecia androgenica.

Info

Publication number
MX2016014962A
MX2016014962A MX2016014962A MX2016014962A MX2016014962A MX 2016014962 A MX2016014962 A MX 2016014962A MX 2016014962 A MX2016014962 A MX 2016014962A MX 2016014962 A MX2016014962 A MX 2016014962A MX 2016014962 A MX2016014962 A MX 2016014962A
Authority
MX
Mexico
Prior art keywords
association
tetrapeptide
glyceryl ester
androgenic alopecia
treating androgenic
Prior art date
Application number
MX2016014962A
Other languages
English (en)
Inventor
Poigny Stéphane
Leveque Marguerite
LEMERCIER Laetitia
Original Assignee
Pierre Fabre Dermo-Cosmetique *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo-Cosmetique * filed Critical Pierre Fabre Dermo-Cosmetique *
Publication of MX2016014962A publication Critical patent/MX2016014962A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se relaciona con una asociación que comprende un péptido que contiene la secuencia A-Lys-Gly-His-Lys-NH2, en donde A es el radical correspondiente a un ácido graso C1 a C18 saturado o insaturado, y laurato de glicerilo o uno de los derivados del mismo. La invención también se relaciona con el uso del mismo para estimular el crecimiento del cabello.
MX2016014962A 2014-05-16 2015-05-13 Asociacion de un tetrapeptido y un ester de glicerilo para el tratamiento contra alopecia androgenica. MX2016014962A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1454401A FR3020951B1 (fr) 2014-05-16 2014-05-16 Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique.
PCT/EP2015/060644 WO2015173326A1 (fr) 2014-05-16 2015-05-13 Association d'un tétrapeptide et d'un glycéryl ester pour le traitement de l'alopécie androgénique.

Publications (1)

Publication Number Publication Date
MX2016014962A true MX2016014962A (es) 2017-04-06

Family

ID=51982648

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016014962A MX2016014962A (es) 2014-05-16 2015-05-13 Asociacion de un tetrapeptido y un ester de glicerilo para el tratamiento contra alopecia androgenica.

Country Status (12)

Country Link
US (1) US9993518B2 (es)
EP (1) EP3142682B1 (es)
JP (1) JP2017524724A (es)
KR (1) KR20170003685A (es)
CN (1) CN106456702A (es)
AU (1) AU2015261537A1 (es)
BR (1) BR112016026637A2 (es)
CA (1) CA2948937A1 (es)
FR (1) FR3020951B1 (es)
MX (1) MX2016014962A (es)
RU (1) RU2016148689A (es)
WO (1) WO2015173326A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108079309B (zh) * 2018-02-02 2021-04-20 福建龙生生物科技有限公司 一种促进透皮吸收组合物及其应用
IT201800002630A1 (it) 2018-02-13 2019-08-13 Giuliani Spa Composizione per la prevenzione e il trattamento dei disturbi della crescita dei capelli
KR102231463B1 (ko) * 2018-06-08 2021-03-24 경북대학교 산학협력단 남성호르몬 수용체 및 ddx5 단백질 간의 결합을 억제하는 융합 펩티드 및 이를 유효성분으로 포함하는 남성형 탈모 예방 또는 치료용 조성물
KR20230047691A (ko) * 2021-10-01 2023-04-10 (주)케어젠 탈모 방지 또는 발모 촉진 활성을 갖는 펩타이드와 이의 용도
KR20230047688A (ko) * 2021-10-01 2023-04-10 (주)케어젠 탈모 방지 또는 발모 촉진 활성을 갖는 펩타이드와 이의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508147A (ja) * 1991-06-07 1994-09-14 ミネソタ　マイニング　アンド　マニュファクチャリング　カンパニー 動物用消毒シャンプー組成物
FR2836040B1 (fr) 2002-02-19 2004-04-16 Fabre Pierre Dermo Cosmetique Association de diguanosine tetraphosphate et de derives nicotiniques, destines aux traitements des desordres capillaires, notamment pour lutter contre la chute des cheveux
JP3974426B2 (ja) 2002-02-25 2007-09-12 住友ゴム工業株式会社 短繊維入りゴムシートの押出形成装置
KR101007637B1 (ko) * 2002-12-30 2011-01-12 장-노엘 또렐 피부 대사 생체 활성제
FR2849375B1 (fr) * 2002-12-30 2006-10-20 Jean Noel Thorel Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
FR2857597B1 (fr) 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
CA2692190C (en) * 2007-06-29 2015-06-02 Innovactiv Inc. Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
US20120195969A1 (en) * 2010-09-29 2012-08-02 Aidan Research And Consulting, Llc Treatment of acne by conditioned media
FR2983858B1 (fr) 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese

Also Published As

Publication number Publication date
RU2016148689A3 (es) 2018-12-29
US20170080046A1 (en) 2017-03-23
BR112016026637A2 (pt) 2017-10-31
KR20170003685A (ko) 2017-01-09
FR3020951A1 (fr) 2015-11-20
US9993518B2 (en) 2018-06-12
RU2016148689A (ru) 2018-06-20
EP3142682A1 (fr) 2017-03-22
JP2017524724A (ja) 2017-08-31
FR3020951B1 (fr) 2016-06-17
AU2015261537A1 (en) 2017-01-12
WO2015173326A1 (fr) 2015-11-19
EP3142682B1 (fr) 2018-11-28
CN106456702A (zh) 2017-02-22
CA2948937A1 (fr) 2015-11-19

Similar Documents

Publication Publication Date Title
CY1122603T1 (el) Γαμμα-δικετονες για τη θεραπευτικη αντιμετωπιση και την προληψη της γηρανσης του δερματος και των ρυτιδων
MX2016014962A (es) Asociacion de un tetrapeptido y un ester de glicerilo para el tratamiento contra alopecia androgenica.
PH12019501763A1 (en) Method of reducing neutropenia
IL268850A (en) Combinations of 4-pyrimidinesulfamide derivatives with active ingredients for the treatment of endothelin-related diseases
MX362349B (es) Composicion que contiene minoxidil para el crecimiento del pelo.
EP3300731A4 (en) HAIR-REPAIRING / GROWTH-STIMULATING ACTIVE AGENT
ZA202007055B (en) Compositions for the treatment of skin conditions
IL281679A (en) Treatment of skin glands through the application of non-thermal energy
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
SG11202010294RA (en) Compositions for the treatment of skin conditions
EP3185872A4 (en) Formulations of testosterone and methods of treatment therewith
EP3579888C0 (en) COMPOSITIONS FOR THE ELECTROCHEMICAL GENERATION OF GAS TRANSMITTERS AND METHODS FOR THE USE THEREOF, AND WOUND DRESSINGS AND TREATMENT SYSTEMS THEREOF
MX2017000374A (es) Metodos y composiciones que regulan el crecimiento del pelo.
PH12017501980A1 (en) The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of digital ulcers (du) concomitant to systemic sclerosis (ssc)
EP3713583A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF THE SKIN
IL256249A (en) The vehicle for treating hair loss and increasing its growth
PH12020550871A1 (en) Process for the preparation of opicapone and intermediates thereof
EP3423064A4 (en) TESTOSTERONE FORMULATIONS AND METHODS OF TREATMENT THEREFOR
IL269401A (en) Mitochondrial preparations for skin and hair care
MX366682B (es) Composición de colutorio.
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.
MX2019010640A (es) Formas cristalinas de acido obeticolico.
IL283964A (en) History of testosterone active ester, preparations and their uses
EP3225237A4 (en) Fatty acid amides for the prevention and/or treatment of steatohepatitis
MY180077A (en) Use of one or more fatty acid esters as insecticide and/or arachnicide

Legal Events

Date Code Title Description
FG Grant or registration